News | August 06, 2013

Reg Refine's newest application allows users to tackle tough deformations

MIM Software Highlights Deformable Breakthrough for HDR

August 6, 2013 — MIM Software Inc. announced newest application yet for Reg Refine in radiation oncology: dose deformation for high-dose rate (HDR) and external beam radiation therapy (EBRT) treatment plans.

Combined with MIM’s recently enhanced Biological Effective Dose modeling tools, the toughest radiation dose accumulation cases are now possible. Reg Refine (patent pending) is a deformable accuracy evaluation and correction tool that allows users to tackle the toughest deformations with confidence and detect and correct deformable errors in areas of interest.  It also allows multi-modality deformation, including deformation from diagnostic magnetic resonance (MR) to HDR planning computed tomography (CT).

For more information: www.mimsoftware.com


Additional Content

News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
News | Women's Health

May 6, 2026 — GE HealthCare has announced the availability of MIM ComboTherapy GYN HDR/EBRT2, a solution designed to ...

Time May 06, 2026
arrow
News | Radiation Therapy

April 30, 2026 — The Siemens Healthineers business area, Varian, has been awarded up to $60 million over five years by ...

Time April 30, 2026
arrow
News | Radiology Business

April 10, 2026 — The radiation therapy team at The Ohio State University Wexner Medical Center, The James Cancer ...

Time April 10, 2026
arrow
Subscribe Now